Skip to main content
. 2020 Apr 25;10(5):667. doi: 10.3390/biom10050667

Figure 2.

Figure 2

Bipartite directed sub-network of two cancer drugs (Venetoclax and Cyclophosphamine) and their target cancer genes: 13 oncogenes (blue); 8 tumor-suppressors (green); and 3 other cancer-related genes (grey) with an unassigned role. The links (grey arrows) show the significant correlation found between the expression profiles of the genes and the activity of the drugs, tested in cancer cell lines.